BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29119564)

  • 1. Intracranial hemorrhages in neonates born from 32 weeks of gestation-low frequency of associated fetal and neonatal alloimmune thrombocytopenia: a register-based study.
    Refsum E; Håkansson S; Mörtberg A; Wikman A; Westgren M
    Transfusion; 2018 Jan; 58(1):223-231. PubMed ID: 29119564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
    de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M
    Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.
    Wienzek-Lischka S; König IR; Papenkort EM; Hackstein H; Santoso S; Sachs UJ; Bein G
    Transfusion; 2017 Mar; 57(3):533-540. PubMed ID: 28019029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
    Delbos F; Bertrand G; Croisille L; Ansart-Pirenne H; Bierling P; Kaplan C
    Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune Thrombocytopenia.
    Santoso S; Wihadmadyatami H; Bakchoul T; Werth S; Al-Fakhri N; Bein G; Kiefel V; Zhu J; Newman PJ; Bayat B; Sachs UJ
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1517-24. PubMed ID: 27283740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
    Kjeldsen-Kragh J; Bengtsson J
    Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study.
    de Vos TW; Winkelhorst D; Árnadóttir V; van der Bom JG; Canals Surís C; Caram-Deelder C; Deschmann E; Haysom HE; Hverven HBC; Lozar Krivec J; McQuilten ZK; Muñiz-Diaz E; Nogués N; Oepkes D; Porcelijn L; van der Schoot CE; Saxonhouse M; Sola-Visner M; Tiblad E; Tiller H; Wood EM; Young V; Železnik M; de Haas M; Lopriore E
    Lancet Haematol; 2022 Nov; 9(11):e844-e853. PubMed ID: 36108655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-human platelet antigen-5b antibodies and fetal and neonatal alloimmune thrombocytopenia; incidental association or cause and effect?
    Alm J; Duong Y; Wienzek-Lischka S; Cooper N; Santoso S; Sachs UJ; Kiefel V; Bein G
    Br J Haematol; 2022 Jul; 198(1):14-23. PubMed ID: 35383895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
    Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
    Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal and neonatal alloimmune thrombocytopenia.
    van den Akker ES; Oepkes D
    Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):3-14. PubMed ID: 17936686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.
    Yougbaré I; Lang S; Yang H; Chen P; Zhao X; Tai WS; Zdravic D; Vadasz B; Li C; Piran S; Marshall A; Zhu G; Tiller H; Killie MK; Boyd S; Leong-Poi H; Wen XY; Skogen B; Adamson SL; Freedman J; Ni H
    J Clin Invest; 2015 Apr; 125(4):1545-56. PubMed ID: 25774504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetomaternal alloimmune thrombocytopenia.
    Ahya R; Turner ML; Urbaniak SJ;
    Transfus Apher Sci; 2001 Oct; 25(2):139-45. PubMed ID: 11761276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe intracranial haemorrhage in neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1b: Case report and literature review.
    Tomac G; Gojčeta K; Grizelj R; Coen Herak D; Ostojić SB; Golubić Ćepulić B
    Transfus Med; 2022 Aug; 32(4):269-275. PubMed ID: 35730350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies.
    Ernstsen SL; Ahlen MT; Johansen T; Bertelsen EL; Kjeldsen-Kragh J; Tiller H
    Am J Obstet Gynecol; 2022 Sep; 227(3):506.e1-506.e12. PubMed ID: 35500612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal alloimmune antibodies against HPA and HLA class I antigens are associated with reduced birthweight among healthy neonates delivered by Chinese women.
    Xue Y; Xin W; Li C; Zeng X; Song Z; Cao C; Zhao T
    Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1215-1219. PubMed ID: 35871773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach.
    Lieberman L; Greinacher A; Murphy MF; Bussel J; Bakchoul T; Corke S; Kjaer M; Kjeldsen-Kragh J; Bertrand G; Oepkes D; Baker JM; Hume H; Massey E; Kaplan C; Arnold DM; Baidya S; Ryan G; Savoia H; Landry D; Shehata N;
    Br J Haematol; 2019 May; 185(3):549-562. PubMed ID: 30828796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia.
    Matusiak K; Patriquin CJ; Deniz S; Dzaja N; Smith JW; Wang G; Nazy I; Kelton JG; Arnold DM
    Transfusion; 2022 Nov; 62(11):2213-2222. PubMed ID: 36239096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening.
    Williamson LM; Hackett G; Rennie J; Palmer CR; Maciver C; Hadfield R; Hughes D; Jobson S; Ouwehand WH
    Blood; 1998 Oct; 92(7):2280-7. PubMed ID: 9746765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the role of maternal anti-HLA class I antibodies in fetal and neonatal thrombocytopenia-Antibody specificity analysis using epitope data.
    Dahl J; Refsum E; Ahlen MT; Egeland T; Jensen T; Viken MK; Stuge TB; Acharya G; Husebekk A; Skogen B; Tiller H
    J Reprod Immunol; 2017 Aug; 122():1-9. PubMed ID: 28686909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PREVFNAIT prevention of foetal/neonatal alloimmune thrombocytopenia (FNAIT) in Polish foetuses and newborns--the PREVFNAIT program].
    Uhrynowska ME; Dębska M; Guz K; Orzińska A; Wróbel A; Maślanka K; Dębski R; Brojer E
    Ginekol Pol; 2015 Jan; 86(1):62-6. PubMed ID: 25775877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.